Factory 99% Isoniazid Powder CAS 54-85-3 Chemical Intermediate Isoniazid

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A735
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Isoniazid
• CAS: 54-85-3
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 1g
• Function: Chemical Intermediate
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Isoniazid
Appearance	White Powder
CAS NO.	54-85-3
MF	C6H7N3O
Storage	Keep in a cool, dry, dark location

 

Isoniazid, also known as isonicotinylhydrazide (INH), is an antibiotic drug primarily used in the treatment and prevention of tuberculosis (TB). It belongs to a class of medications known as antituberculars and has been a cornerstone in TB therapy for decades.

 

1. Treatment of Tuberculosis: Isoniazid is a key component in the standard regimen for treating active TB, often combined with other drugs like rifampicin, pyrazinamide, and ethambutol to ensure effective eradication of the Mycobacterium tuberculosis bacteria.
2. Latent Tuberculosis Infection: It is also prescribed for the prevention of active TB in individuals with latent TB infection, particularly those at high risk of developing the disease, such as those with weakened immune systems or close contacts of TB patients.
3. Combination Therapy: Its use in combination with other antitubercular drugs helps to prevent the emergence of drug-resistant strains and ensures a higher success rate in treatment outcomes.

1. Bacterial Inhibition: Isoniazid functions by inhibiting the synthesis of mycolic acids, which are essential components of the Mycobacterium tuberculosis cell wall. This disruption leads to the lysis (breakdown) of the bacterial cells and eventual eradication of the pathogen.
2. Enhancement of Immune Response: Although its primary mechanism is direct bacterial inhibition, isoniazid may also indirectly enhance the host's immune response to TB by reducing the bacterial load and allowing the immune system to more effectively target and clear the remaining infection.
3. Prevention of Drug Resistance: By being part of a multidrug regimen, isoniazid contributes to the prevention of the development of drug-resistant strains of Mycobacterium tuberculosis, which are increasingly becoming a global health concern.